0000950123-17-001390.txt : 20170210 0000950123-17-001390.hdr.sgml : 20170210 20170210100110 ACCESSION NUMBER: 0000950123-17-001390 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170210 DATE AS OF CHANGE: 20170210 EFFECTIVENESS DATE: 20170210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Omega Fund Management, LLC CENTRAL INDEX KEY: 0001637359 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16844 FILM NUMBER: 17590182 BUSINESS ADDRESS: STREET 1: 185 DARTMOUTH STREET, SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617 502 6538 MAIL ADDRESS: STREET 1: 185 DARTMOUTH STREET, SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Omega Fund Management (US) Inc. DATE OF NAME CHANGE: 20150320 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001637359 XXXXXXXX 12-31-2016 12-31-2016 Omega Fund Management, LLC
185 Dartmouth Street, Suite 502 Boston MA 02116
13F HOLDINGS REPORT 028-16844 N
Anne-Mari Paster Chief Financial Officer, Omega Fund Management, LLC 617-502-6538 /s/ Anne-Mari Paster Boston MA 02-09-2017 0 12 123236 false
INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Cidara Therapeutics Common Stock 171757107 5149 495050 SH SOLE 495050 0 0 CymaBay Therapeutics Common Stock 23257D103 522 301477 SH SOLE 301477 0 0 Dicerna Pharmaceuticals Common Stock 253031108 644 223457 SH SOLE 223457 0 0 Editas Medicine Common Stock 28106W103 1074 66162 SH SOLE 66162 0 0 Egalet Common Stock 28226B104 22108 2889926 SH SOLE 2889926 0 0 ESSA Pharma Common Stock 29668H104 3716 1696969 SH SOLE 1696969 0 0 FibroGen Common Stock 31572Q808 17595 822175 SH SOLE 822175 0 0 Juno Therapeutics Common Stock 48205A109 23176 1229512 SH SOLE 1229512 0 0 Nabriva Therapeutics Sponsored ADR 62957M104 6830 1145890 SH SOLE 1145890 0 0 Paratek Pharmaceuticals Common Stock 699374302 40046 2600410 SH SOLE 2600410 0 0 Pieris Pharmaceuticals Common Stock 720795103 2376 1697384 SH SOLE 1697384 0 0 Proteon Therapeutics Common Stock 74371L109 0 0 SH SOLE 0 0 0